SecurityGSK / GlaxoSmithKline plc
InstitutionBell State Bank & Trust
Shares44,784
Value $ 1,805,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Bell State Bank & Trust reports 3.14% decrease in ownership of GSK / GlaxoSmithKline plc

August 14, 2018 - Bell State Bank & Trust has filed a 13F-HR form disclosing ownership of 44,784 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $1,805,000 USD as of June 30, 2018. Bell State Bank & Trust had filed a previous 13F-HR on May 14, 2018 disclosing 46,235 shares of GlaxoSmithKline plc at a value of $1,806,000 USD. This represents a change in shares of -3.14 percent and a change in value of -0.06 percent during the quarter.

Other investors with positions similar to Bell State Bank & Trust include Bnp Paribas Arbitrage, Sa, Voya Financial Advisors, Inc., BancorpSouth Inc, Pinnacle Associates Ltd, Moors & Cabot, Inc., and Greenwich Wealth Management LLC.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.68 44,784 -3.14 1,805 -0.06 -58 57 3.13
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 37.27 46,235 3.43 1,806 13.87 57 163 10.26
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 38.04 44,700 -13.93 1,586 -24.80 -275 -248 -11.74
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.86 51,937 0.92 2,109 -4.96 20 -130 -5.85
2017-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 42.64 51,464 -2.27 2,219 -0.05 -51 50 2.26
2017-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.33 52,662 17.98 2,220 29.14 324 177 10.31
2016-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.82 44,635 7.05 1,719 -4.39 120 -199 -11.06
2016-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41,697 0.00 1,798 1,798 0
2016-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 0 0 0 0
2015-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 0 -100.00 0 -100.00 0 0
2015-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.04 31,785 -14.66 1,222 -21.21 -219 -110 -7.12
2015-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 43.89 37,245 -2.73 1,551 -12.22 -46 -170 -9.63
2015-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 44.45 38,291 2.19 1,767 10.30 36 129 8.03
2014-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 44.37 37,472 78.00 1,602 65.50 729 -95 -9.76
2014-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 49.73 21,052 12.03 968 -3.68 112 -149 -14.87
2014-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 18,791 1,005


CUSIP: 37733W105